Loading…
Loading…
Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Envista (NYSE: NVST - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Valuation and Earnings This table compares Stagezero Life
Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Fonar (NASDAQ: FONR - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Insider and Institutional Ownership 50.6% of Fonar
Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Insulet (NASDAQ: PODD - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership. Earnings and Valuation This table compares Stagezero Life
Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and TriSalus Life Sciences (NASDAQ: TLSI - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings. Valuation and Earnings This table
TORONTO, ON - TheNewswire - May 13, 202 5 - StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), and ElevationMD ( “ElevationMD”) today announced the introduction of Aristotle and AVRT for the early detection of cancer as well as screening for metabolic markers for identifying and managing the early warning signs of chronic disease for the prevention of cancer. StageZero is an integrated healthcare company with the first and only mRNA gene expression multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, and AVRT, an oncologist-led metabolic screening and treatment protocol for detecting the early warning signs of cancer and chronic disease, together with ElevationMD today announced they are introducing state of the art early cancer screening to ElevationMD's patients in British Columbia.
TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene expression multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, and an oncologist-led adjunctive metabolic treatment protocol with early data - METRICS study - showing an improvement in outcome in cancer patients, today announced further to its press releases of April 2, 2024, April 4, 2024, April 9, 2024, May 23, 2024 and July 3, 2024, an update regarding its progress toward filing the full year 2023 financials and associated documents.
TORONTO, ON / ACCESSWIRE / July 3, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene expression multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, and an oncologist-led adjunctive metabolic treatment protocol with early data - METRICS study - showing an improvement in outcome in cancer patients, today announced further to its press releases of April 2, 2024, April 4, 2024, April 9, 2024 and May 23, 2024, an update regarding its progress toward filing the full year 2023 financials and associated documents.
StageZero Life Sciences Ltd. (OTCQB:SZLSF) Q1 2024 Results Conference Call May 21, 2024 8:00 AM ET Company Participants Rebecca Greco - Head Investor Relations James Howard Tripp - Chairman & Chief Executive Officer Operator Good morning everyone, and welcome to the StageZero Life Sciences First Quarter Financials Call.
No recent filings indexed.